Skip to main content

Table 3 Excluded full texts based on eligibility criteria

From: Medicines and vaccines supply chains challenges in Nigeria: a scoping review

SN Authors Title Year Reason
1 (Millar et al., 2014) Patterns and predictors of malaria care-seeking, diagnostic testing, and artemisinin-based combination therapy for children under five with fever in Northern Nigeria: a cross-sectional study 2014 Irrelevant because it does not focus on medicine supply chain challenges
2 (Unger et al., 2014) Treating diarrhoeal disease in children under
five: the global picture
2014 Irrelevant because the full text does not capture study variables
3 (Mangham-jefferies et al., 2014) What determines providers’ stated preference for the treatment of uncomplicated malaria? 2014 Irrelevant because the full text does not capture study variables
4 (Palafox, n.d.) Mapping the private commercial sector distribution chain for antimalarials in six low-income countries in Africa and South East Asia 2014 Irrelevant because the full text does not capture study variables
5 (Obitte et al., 2009) Survey of drug storage practice in homes, hospitals, and patent medicine stores in Nsukka, Nigeria 2020 Irrelevant because the full text does not capture study variables
6 Babalola, Stella and Lawan, Umar Factors predicting BCG
immunization status in northern Nigeria: a behavioral-ecological perspective
2009 Irrelevant because the full text does not capture study variables
7 Urban, Boris Interventions to increase the distribution of vaccines in Sub-Saharan
Africa: a scoping review
2019 Irrelevant because the full text does not capture study variables
8 (Karp et al., 2015) Evaluating the value proposition for improving vaccine
thermostability to increase vaccine impact in low and middle-income countries
2018 Irrelevant because the full text does not capture study variables
9 (Bassey et al., 2018) The global switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV): facts, experiences and lessons learned from the south-south zone; Nigeria, April 2016 2018 Irrelevant because the full text does not capture study variables
10 (Odume, 2020) Taking tuberculosis preventive therapy implementation to national scale: the Nigerian PEPFAR Program experience 2020 Irrelevant because the full text does not capture study variables
11 (Griswold et al., 2018) Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria 2018 Irrelevant because the full text does not capture study variables
12 (Petersen et al., 2017) Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab 2017 Irrelevant because the full text does not capture study variables
13 (Mangham-jefferies et al., 2015) Mind the gap: knowledge and practice of providers treating uncomplicated malaria at public and mission health facilities, pharmacies and drug stores in Cameroon and Nigeria 2015 Irrelevant because the full text does not capture study variables
14 (Rao et al., 2017) Immunization supply chains: Why they matter and how they are changing 2017 Irrelevant because the full text does not capture study variables
15 (Wright et al., 2017) Improving iSC performance through outsourcing – Considerations for using third-party service providers to increase innovation, capacity, and efficiency 2017 Irrelevant because the full text does not capture study variables
16 (Ward & Kynvin, 2015) Consumer-focused supply chains: a cross-case comparison of medicine appeal and acceptance in India, Uganda, and Nigeria 2015 Irrelevant because the full text does not capture study variables
17 (Molemodile et al., 2017) Evaluation of a pilot intervention to redesign the decentralised vaccine supply chain system in Nigeria 2017 Irrelevant because the full text does not capture study variables
  (Osadebe et al., 2017) Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April – November 2015 2017 Irrelevant because the full text does not capture study variables
18 (Hirsh Bar Gai et al., 2018) Evaluating scenarios of locations and capacities for vaccine storage in Nigeria   Irrelevant because the full text does not capture study variables
19 (Bangura et al., 2020) Barriers to Childhood Immunization in Sub-Saharan Africa: A Systematic Review 2020 Irrelevant because the full text does not capture study variables
20 (Daniel & Oladapo, 2006) Default from tuberculosis treatment programme in Sagamu, Nigeria Default from Tuberculosis Treatment Programme in Sagamu, Nigeria 2006 Irrelevant because the full text does not capture study variables
21 (Ikoh et al., 2009) The influence of “Stock Out” on health-seeking behaviour of low-income women in Uyo urban, Akwa Ibom State, Nigeria 2009 Irrelevant because the full text does not capture study variables
22 (Aina et al., 2017) Preliminary results from direct-to-facility vaccine deliveries in Kano, Nigeria 2017 Irrelevant because the full text does not capture study variables
23 (Tougher et al., 2009) The private commercial sector distribution chain for antimalarial drugs in Benin Findings from a rapid survey 2009 Irrelevant because the full text does not capture study variables
24 (Brien et al., 2018) Treat the Pain Program Megan 2018 Irrelevant because the full text does not capture study variables
25 (Monath et al., 2016) Yellow fever vaccine supply: A possible solution 2016 Irrelevant because the full text does not capture study variables
26 (Sutter & Cochi, 2019) Inactivated Poliovirus Vaccine Supply Shortage: Is There Light at the End of the Tunnel? 2019 Editorial comment
27 (Oleribe et al., 2017) Individual and socioeconomic factors associated with childhood immunization coverage in Nigeria 2017 Irrelevant because the full text does not capture study variables